• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immense Insulin Intestinal Uptake and Lymphatic Transport Using Bile Acid Conjugated Partially Uncapped Liposome.利用胆汁酸偶联部分未封端脂质体实现胰岛素的大量肠道摄取和淋巴转运。
Mol Pharm. 2018 Oct 1;15(10):4756-4763. doi: 10.1021/acs.molpharmaceut.8b00708. Epub 2018 Aug 29.
2
A Delivery System for Oral Administration of Proteins/Peptides Through Bile Acid Transport Channels.通过胆汁酸转运通道口服给予蛋白质/肽的递药系统。
J Pharm Sci. 2019 Jun;108(6):2143-2152. doi: 10.1016/j.xphs.2019.01.027. Epub 2019 Feb 2.
3
Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.载胰岛素脂质体在大鼠中的降血糖活性和口服生物利用度:胆酸盐类型、粒径和给药剂量的影响。
Eur J Pharm Biopharm. 2012 Jun;81(2):265-72. doi: 10.1016/j.ejpb.2012.02.009. Epub 2012 Feb 18.
4
Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.功能性纳米颗粒利用胆酸途径克服肠道上皮的多重屏障,用于口服胰岛素传递。
Biomaterials. 2018 Jan;151:13-23. doi: 10.1016/j.biomaterials.2017.10.022. Epub 2017 Oct 13.
5
Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport.口服纳米颗粒具有特定的高效肠道摄取和淋巴转运特性。
ACS Nano. 2018 Sep 25;12(9):8893-8900. doi: 10.1021/acsnano.8b04315. Epub 2018 Aug 8.
6
Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study.载胰岛素脂质体经胆汁盐增强口服吸收:机制研究。
Int J Pharm. 2014 Jan 2;460(1-2):119-30. doi: 10.1016/j.ijpharm.2013.11.028. Epub 2013 Nov 23.
7
Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids.经胆汁酸的肠肝循环实现载胰岛素纳米粒的肝靶向递送。
Drug Deliv. 2018 Nov;25(1):1224-1233. doi: 10.1080/10717544.2018.1469685.
8
Absorption Mechanism of a Physical Complex of Monomeric Insulin and Deoxycholyl-l-lysyl-methylester in the Small Intestine.单体胰岛素与脱氧胆酰-L-赖氨酰甲酯物理复合物在小肠中的吸收机制
Mol Pharm. 2015 Jun 1;12(6):1911-20. doi: 10.1021/mp500626a. Epub 2015 May 4.
9
Enhancing oral bioavailability of insulin through bilosomes: Implication of charge and chain length on apical sodium-dependent bile acid transporter (ASBT) uptake.通过双分子层囊泡提高胰岛素的口服生物利用度:电荷和链长对顶端钠依赖性胆汁酸转运体(ASBT)摄取的影响。
Int J Biol Macromol. 2023 Dec 1;252:126565. doi: 10.1016/j.ijbiomac.2023.126565. Epub 2023 Aug 26.
10
The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer.各种脂质体制剂对胰岛素透过Caco-2细胞单层的影响。
Life Sci. 2004 Oct 22;75(23):2819-27. doi: 10.1016/j.lfs.2004.05.027.

引用本文的文献

1
Characterization of Taurocholic Acid Binding With Insulin for Potential Oral Formulation Using Different Methods.采用不同方法对牛磺胆酸与胰岛素结合用于潜在口服制剂的表征。
Electrophoresis. 2025 Apr;46(7-8):468-477. doi: 10.1002/elps.8139. Epub 2025 Apr 16.
2
Nanoparticle and microparticle-based systems for enhanced oral insulin delivery: A systematic review and meta-analysis.基于纳米颗粒和微粒的增强口服胰岛素递送系统:系统评价与荟萃分析
J Nanobiotechnology. 2024 Dec 29;22(1):802. doi: 10.1186/s12951-024-03045-8.
3
Design and Application of pH-Responsive Liposomes for Site-Specific Delivery of Cytotoxin from .pH 响应脂质体的设计与应用,用于细胞毒素的靶向递释。
Int J Nanomedicine. 2024 Jun 6;19:5381-5395. doi: 10.2147/IJN.S461728. eCollection 2024.
4
Exploiting Apical Sodium-Dependent Bile Acid Transporter (ASBT)-Mediated Endocytosis with Multi-Functional Deoxycholic Acid Grafted Alginate Amide Nanoparticles as an Oral Insulin Delivery System.利用多官能基去氧胆酸接枝海藻酸钠酰胺纳米粒经顶端钠依赖性胆酸转运蛋白(ASBT)介导的内吞作用作为口服胰岛素递药系统。
Pharm Res. 2024 Feb;41(2):335-353. doi: 10.1007/s11095-023-03641-7. Epub 2023 Dec 19.
5
Nanomedicine for Maternal and Fetal Health.纳米医学与母婴健康。
Small. 2024 Oct;20(41):e2303682. doi: 10.1002/smll.202303682. Epub 2023 Oct 10.
6
Oral nano-formulation improves pancreatic islets dysfunction lymphatic transport for antidiabetic treatment.口服纳米制剂改善胰岛功能障碍及淋巴转运以用于抗糖尿病治疗。
Acta Pharm Sin B. 2023 Jul;13(7):3137-3152. doi: 10.1016/j.apsb.2022.12.014. Epub 2022 Dec 22.
7
Nanotechnologies for Physiology-Informed Drug Delivery to the Lymphatic System.用于向淋巴系统输送药物的基于生理学的纳米技术。
Annu Rev Biomed Eng. 2023 Jun 8;25:233-256. doi: 10.1146/annurev-bioeng-092222-034906. Epub 2023 Mar 31.
8
Production of high loading insulin nanoparticles suitable for oral delivery by spray drying and freeze drying techniques.喷雾干燥和冷冻干燥技术生产适合口服的高载胰岛素纳米粒。
Sci Rep. 2022 Jun 15;12(1):9949. doi: 10.1038/s41598-022-13092-6.
9
Bile Acid Conjugation on Solid Nanoparticles Enhances ASBT-Mediated Endocytosis and Chylomicron Pathway but Weakens the Transcytosis by Inducing Transport Flow in a Cellular Negative Feedback Loop.固体纳米粒子上的胆汁酸结合增强了 ASBT 介导的内吞作用和乳糜微粒途径,但通过诱导细胞负反馈循环中的运输流,减弱了跨细胞转运。
Adv Sci (Weinh). 2022 Jul;9(21):e2201414. doi: 10.1002/advs.202201414. Epub 2022 Jun 2.
10
Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures.多功能口服胰岛素递药纳米系统:从材料到纳米结构。
Int J Mol Sci. 2022 Mar 20;23(6):3362. doi: 10.3390/ijms23063362.

本文引用的文献

1
Oral Nanoparticles Exhibit Specific High-Efficiency Intestinal Uptake and Lymphatic Transport.口服纳米颗粒具有特定的高效肠道摄取和淋巴转运特性。
ACS Nano. 2018 Sep 25;12(9):8893-8900. doi: 10.1021/acsnano.8b04315. Epub 2018 Aug 8.
2
Oral insulin delivery: a chimera?
Int J Pharm. 2015 Nov 10;495(1):218-219. doi: 10.1016/j.ijpharm.2015.08.092. Epub 2015 Sep 7.
3
Facile synthesis of partially uncapped liposomes.部分未封端脂质体的简便合成
Colloids Surf B Biointerfaces. 2015 Nov 1;135:143-149. doi: 10.1016/j.colsurfb.2015.07.050. Epub 2015 Jul 28.
4
Causative anti-diabetic drugs and the underlying clinical factors for hypoglycemia in patients with diabetes.导致糖尿病患者低血糖的降糖药物及潜在临床因素。
World J Diabetes. 2015 Feb 15;6(1):30-6. doi: 10.4239/wjd.v6.i1.30.
5
Biopharmaceutical benchmarks 2014.2014年生物制药基准
Nat Biotechnol. 2014 Oct;32(10):992-1000. doi: 10.1038/nbt.3040.
6
Functional transformations of bile acid transporters induced by high-affinity macromolecules.高亲和力大分子诱导的胆汁酸转运体的功能转变
Sci Rep. 2014 Feb 25;4:4163. doi: 10.1038/srep04163.
7
Oral delivery of taurocholic acid linked heparin-docetaxel conjugates for cancer therapy.口服递送牛磺胆酸连接肝素-多西他赛缀合物用于癌症治疗。
J Control Release. 2013 Aug 28;170(1):74-82. doi: 10.1016/j.jconrel.2013.04.024. Epub 2013 May 9.
8
Role of the intestinal bile acid transporters in bile acid and drug disposition.肠道胆汁酸转运体在胆汁酸和药物处置中的作用。
Handb Exp Pharmacol. 2011(201):169-203. doi: 10.1007/978-3-642-14541-4_4.
9
Using the lymph fistula rat model to study incretin secretion.利用淋巴瘘大鼠模型研究肠促胰岛素分泌。
Vitam Horm. 2010;84:221-49. doi: 10.1016/B978-0-12-381517-0.00008-4.
10
Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.海藻酸钠-壳聚糖微球的制备及其用于胰岛素口服给药的评价。
Eur J Pharm Biopharm. 2011 Jan;77(1):11-9. doi: 10.1016/j.ejpb.2010.09.016. Epub 2010 Oct 7.

利用胆汁酸偶联部分未封端脂质体实现胰岛素的大量肠道摄取和淋巴转运。

Immense Insulin Intestinal Uptake and Lymphatic Transport Using Bile Acid Conjugated Partially Uncapped Liposome.

机构信息

Department of Pharmaceutics and Pharmaceutical Chemistry , University of Utah , Salt Lake City , Utah 84112 , United States.

Department of Biotechnology , The Catholic University of Korea , 43-1 Yeokgok 2-dong, Wonmi-gu , Bucheon , Gyeonggi-do 420-743 , Republic of Korea.

出版信息

Mol Pharm. 2018 Oct 1;15(10):4756-4763. doi: 10.1021/acs.molpharmaceut.8b00708. Epub 2018 Aug 29.

DOI:10.1021/acs.molpharmaceut.8b00708
PMID:30125508
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6588159/
Abstract

We provide immense insulin absorption from the gastrointestinal tract, combining apical sodium-dependent bile acid transporter-mediated intestinal uptake and the lymphatic transport pathway. This strategy has proven to employ chondroitin sulfate- g-taurocholic acid coated, insulin-loaded partially uncapped liposome (IPUL-CST) for type 1 diabetes mellitus (T1DM) treatment. The loading efficiency of insulin in IPUL-CST increased significantly from 33% to 75% via the partially uncapped liposome preparation method. Moreover, the IPUL-CST revealed an improved insulin protection efficacy in GIT simulated pH and digestive enzyme conditions. The high dose of IPUL-CST in the small intestine was detected 4 h post-oral administration using ex vivo optical imaging and fluorescence intensity. The IPUL-CST exhibited significantly enhanced intestinal absorption (oral bioavailability, 34%; T, 9 h) and reduced blood glucose levels for 16 h in T1DM. The results demonstrated that the new investigated IPUL-CST is a promising carrier for oral insulin delivery.

摘要

我们提供了从胃肠道中大量吸收胰岛素的方法,结合了顶端钠依赖性胆汁酸转运体介导的肠内摄取和淋巴转运途径。这种策略已被证明采用硫酸软骨素 - g-牛磺胆酸包被、载有胰岛素的部分无盖脂质体(IPUL-CST)治疗 1 型糖尿病(T1DM)。通过部分无盖脂质体制备方法,胰岛素在 IPUL-CST 中的装载效率从 33%显著提高到 75%。此外,IPUL-CST 在 GIT 模拟 pH 值和消化酶条件下显示出改善的胰岛素保护效果。口服给药 4 小时后,使用离体光学成像和荧光强度检测到小肠中高剂量的 IPUL-CST。IPUL-CST 表现出显著增强的肠道吸收(口服生物利用度,34%;T,9 h)和降低 T1DM 患者 16 小时的血糖水平。结果表明,新研究的 IPUL-CST 是一种有前途的口服胰岛素传递载体。